MedTrace Logo

Agreement Between Standard and Continuous Wireless Vital Sign Measurements

NCT05325814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-04-19

No results posted yet for this study

Summary

Patients undergoing major surgery are at risk of postoperative complications. Continuous wireless monitoring outside the post-anesthesia or intensive care units may enable early detection of patient deterioration, but good accuracy of measurements is required.

This validation study, which is part of the WARD-SX project, aimed to assess the agreement between vital signs recorded by standard and novel wireless devices

Conditions

  • Postoperative Patients

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Eske K Aasvang, Dr. Med · Rigshospitalet, Denmark

  • Camilla Haahr-Raunkjaer, MD · Rigshospitalet, Denmark

Eligibility

Min Age
60 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2020-07-22
Completion
2020-07-22

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05325814 on ClinicalTrials.gov